Inventor · disambiguated record
Gunda Brandenburg
Also filed as: BRANDENBURG GUNDA
9 granted patents·1 pending application·105 citations·filing 2006–2023
89Inventor score
Top patents by PatentIndex Score
10 records- 0195US8425902B2Monoclonal antibodies against claudin-18 for treatment of cancerSAHIN UGUR·Filed 2008·Granted Apr 23, 2013·20 cites·3 claims
- 0295US8168427B2Monoclonal antibodies against claudin-18 for treatment of cancerSAHIN UGUR·Filed 2006·Granted May 1, 2012·47 cites·5 claims
- 0394US9751934B2Monoclonal antibodies against claudin-18 for treatment of cancerGANYMED PHARMACEUTICALS AG·Filed 2015·Granted Sep 5, 2017·13 cites·20 claims
- 0489US10017564B2Monoclonal antibodies against claudin-18 for treatment of cancerGANYMED PHARMACEUTICALS GMBH·Filed 2016·Granted Jul 10, 2018·6 cites·21 claims
- 0589US9212228B2Monoclonal antibodies against claudin-18 for treatment of cancerSAHIN UGUR·Filed 2012·Granted Dec 15, 2015·9 cites·42 claims
- 0688US2024117022A1Monoclonal antibodies against claudin-18 for treatment of cancerASTELLAS PHARMA INC·Filed 2023·Application pending·0 cites
- 0787US10738108B2Monoclonal antibodies against claudin-18 for treatment of cancerGANYMED PHARMACEUTICALS AG·Filed 2017·Granted Aug 11, 2020·2 cites·28 claims
- 0885US10174104B2Monoclonal antibodies against claudin-18 for treatment of cancerGANYMED PHARMACEUTICALS AG·Filed 2015·Granted Jan 8, 2019·3 cites·24 claims
- 0985US9499609B2Monoclonal antibodies against claudin-18 for treatment of cancerSAHIN UGUR·Filed 2011·Granted Nov 22, 2016·5 cites·21 claims
- 1075US11739139B2Monoclonal antibodies against Claudin-18 for treatment of cancerASTELLAS PHARMA INC·Filed 2020·Granted Aug 29, 2023·0 cites·18 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →